SCHEMBL16607182

SCHEMBL16607182

CC(=O)Nc1ccc(C(=O)Nc2nc(-c3ccccc3)c(C)s2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
KDM4E B2RXH2 2/20 0.64
LMNA P02545 2/20 0.64
POLB P06746 1/20 0.64
KMT2A Q03164 5/20 0.64
NPC1 O15118 5/20 0.64
RAB9A P51151 5/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
NPSR1 Q6W5P4 3/20 0.61
RXFP1 Q9HBX9 1/20 0.61
MEN1 O00255 3/20 0.60
PKM P14618 2/20 0.60
ALOX5 P09917 1/20 0.60
MAPT P10636 2/20 0.59
HPGD P15428 1/20 0.59
NFKB1 P19838 1/20 0.59
NFKB2 Q00653 1/20 0.59
RELA Q04206 1/20 0.59
ADORA3 P0DMS8 2/20 0.58
ADORA1 P30542 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17107156 0.88 ALDH1A1 (0.79) ALDH1A1KDM4ELMNAPOLBKMT2A
SCHEMBL16607177 0.88 NPC1 (0.83) ALDH1A1KDM4ELMNAKMT2ANPC1
SCHEMBL2753568 0.87 ADORA3 (0.73) ALDH1A1KDM4ELMNAPOLBKMT2A
SCHEMBL16607138 0.86 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAPOLBKMT2A
SCHEMBL16607171 0.86 KDM4E (0.61) ALDH1A1KDM4ELMNAKMT2ANPC1
SCHEMBL15086878 0.86 ALOX5 (0.74) ALDH1A1KDM4ELMNAPOLBKMT2A
SCHEMBL16607218 0.85 SMN1; SMN2 (0.60) ALDH1A1KDM4EKMT2ANPC1RAB9A
SCHEMBL16607136 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EKMT2ANPC1RAB9A
SCHEMBL12249187 0.84 ALDH1A1 (0.76) ALDH1A1KDM4ELMNAPOLBKMT2A
SCHEMBL16607188 0.83 KDM4E (0.55) ALDH1A1KDM4ELMNAPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-08-04 US disclosed
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-04-23 US disclosed
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-09-15 US disclosed
US-9364472-B2 Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof NEW YORK UNIVERSITY (US) 2016-06-14 US disclosed
US-9353078-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof NEW YORK UNIVERSITY (US) 2016-05-31 US disclosed
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-04-14 US disclosed
WO-2015050984-A1 AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2015-04-09 WO disclosed
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2015-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 ALDH1A1 3152/4885KDM4E 3803/4885LMNA 1219/4885
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof AGER, IAPP, GPR119 ALDH1A1 3152/4885KDM4E 3803/4885LMNA 1219/4885
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 ALDH1A1 3152/4885KDM4E 3803/4885LMNA 1219/4885
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 ALDH1A1 3152/4885KDM4E 3803/4885LMNA 1219/4885
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof AGER, IAPP, GPR119 ALDH1A1 3152/4885KDM4E 3803/4885LMNA 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.